Aviva’s nine-month trading update opens with numbers that look strong: general insurance premiums up 19%, group combined operating ratio improved to 93.8%. Scroll past those and into the commercial lines table, and a quieter but more instructive picture emerges.
UK commercial gross written premium fell 5% to £2,768 million in the first nine months of 2026. That follows an 8% decline in the first quarter and a 4% drop at the half-year stage, meaning Aviva’s UK commercial book has contracted in every reporting period this year. The company’s explanation has been consistent throughout: deliberate underwriting discipline in a market where rates are still heading down.
What makes the number worth attention is that it sits alongside a UK and Ireland combined operating ratio of 93.0%, improved by 0.6 percentage points year on year. Aviva is writing less and making more from what remains. That is a strategic posture, rather than a temporary reaction.
UK commercial insurance rates fell 8% in the third quarter of 2026, extending a run of consecutive rate declines to 11, according to Marsh’s Global Insurance Market Index for Q3 2026. Property fell 11% in that quarter alone.
Aviva’s UK and Ireland general insurance chief executive Jason Storah said in March 2026, following the company’s full-year results, that it would not “knee-jerk” in response to market softening and would walk away from business where the terms were unsustainable. The Q3 numbers confirm that position has held. Excluding planned actions in certain schemes and Aviva Syndicates, commercial premiums were down 3%, meaning some of the contraction is deliberate portfolio management rather than lost competition.
The refocusing of Aviva’s UK commercial lines business, which involved moving certain large corporate and specialty accounts and launching a new upper mid-market proposition, was designed to concentrate capacity on segments where Aviva can maintain underwriting quality. The practical implication for brokers placing commercial risks, particularly in mid-market and specialty lines, is that submission quality is being scrutinised more closely than price.
While the commercial book contracts, Aviva’s UK personal lines book is expanding rapidly. Personal lines premiums rose 57% over nine months, to £5,256 million, driven largely by the acquisition of Direct Line Group, which completed in July 2025, and the subsequent integration of its books under the Aviva umbrella.
The integration has moved faster than expected. The TUPE process completed earlier in 2026, with approximately 8,000 Direct Line employees transferred to Aviva, according to reports at the time of the half-year results. The company now reports cumulative run-rate cost synergies of approximately £130 million, with the remaining portion of a total capital synergy target of more than £500 million expected to be achieved by year end.
Direct Line policies are now on price comparison websites, and Aviva has since launched pet insurance under the Direct Line brand. Storah has described the specialty personal lines market as a significant growth opportunity. Storah said at the half-year results briefing in August 2026 that Aviva’s share in specialty personal lines sits at around 6% to 7%, against an overall market share of more than 20% across its broader book.
For brokers, the picture is divided. Aviva is investing heavily in the personal lines distribution infrastructure, including digital channels, price comparison website presence, and new product lines, while simultaneously holding the line on commercial terms. Those are different strategic priorities operating in parallel, and the results suggest both are delivering.
Aviva’s guidance for UK and Ireland general insurance is a combined operating ratio below 94% for the full year 2026. With the nine-month ratio at 93.0%, that target looks secure. The company has also signalled that the softer commercial rating environment is expected to persist through the remainder of the year, so the discipline on commercial submissions is unlikely to ease ahead of the January renewal season.
Solvency remains strong. The Solvency II shareholder cover ratio reached 179% at September 30, up from 176% at mid-year, with the company projecting the high-180s by year end once remaining Direct Line capital synergies flow through. Amanda Blanc, group chief executive, said in the trading update that Aviva expects earnings per share to grow broadly in line with its 11% target for 2026.
